Robert M. Centor, MD; Todd McCarty, MD
Disclosures: Dr. Centor has disclosed the following: Honoraria: Medscape. Dr. McCarty has disclosed the following: Research grants/contracts: Amplyx, Cidara. Honoraria: St. Francis Hospital. Consultantship: Mycoses Study Group.
Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Catharine B. Stack, PhD, MS, Deputy Editor, Statistics, reports that she has stock holdings in Pfizer, Johnson & Johnson, and Colgate-Palmolive. Christina C. Wee, MD, MPH, Deputy Editor, reports employment with Beth Israel Deaconess Medical Center. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Yu-Xiao Yang, MD, MSCE, Deputy Editor, reports that he has no financial relationships or interest to disclose.
Audio. Annals On Call - Bacterial Panels: Pros and Cons: Dr. Centor discusses T2Bacteria Panels with Dr. Todd McCarty of the University of Alabama at Birmingham.
Other Audio Options: Download MP3
December 25, 2019
The data will help to decrease antibiotic use in the future
Centor RM, McCarty T. Annals On Call - Bacterial Panels: Pros and Cons. Ann Intern Med. 2019;171:OC1. doi: https://doi.org/10.7326/A19-0012
Download citation file:
Published: Ann Intern Med. 2019;171(5):OC1.
Healthcare Delivery and Policy, Multi-Organ Failure and Sepsis, Pulmonary/Critical Care.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use